Talphera, Inc. (NASDAQ:TLPH) Sees Large Growth in Short Interest

Talphera, Inc. (NASDAQ:TLPH) saw a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 168,300 shares, a growth of 38.9% from the May 15th total of 121,200 shares. Approximately 1.0% of the company’s shares are short sold. Based on an average daily trading volume, of 63,700 shares, the days-to-cover ratio is presently 2.6 days.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Maxim Group initiated coverage on shares of Talphera in a research report on Monday, May 6th. They issued a “buy” rating and a $3.00 price target on the stock. HC Wainwright reiterated a “buy” rating and issued a $6.00 target price on shares of Talphera in a report on Wednesday, May 15th.

Talphera Trading Up 8.2 %

NASDAQ:TLPH traded up $0.08 on Friday, reaching $1.06. The company’s stock had a trading volume of 136,311 shares, compared to its average volume of 37,101. Talphera has a 1-year low of $0.43 and a 1-year high of $1.61. The stock’s 50-day moving average price is $1.04.

Talphera (NASDAQ:TLPH) last issued its quarterly earnings data on Tuesday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.12. Sell-side analysts forecast that Talphera will post -0.84 earnings per share for the current year.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.